A Registry for Children Treated with Proton Radiation Therapy

Overview

About this study

The purpose of the Pediatric Proton Consortium Registry (PPCR) is to enroll children who have been treated with proton radiation in the United States in order to describe the population that currently receives protons and better evaluate its benefits over other therapies. The data collected from this study will help facilitate research on proton beam radiation therapy and allow for collaborative research. The PPCR will collect demographic and clinical data which many centers that deliver proton radiation therapy already collect in routine operations.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Eligibility Criteria:

  • Patients treated with radiation therapy at one of the participating centers.
  • Age < 21 years old at time of treatment start.
  • Patients may be enrolled regardless of previous local or systemic treatments received prior to enrollment in the PPCR.
  • Patients may be enrolled regardless of other current local or systemic treatments or disease extent.
  • Patients may be enrolled on the PPCR concurrently with another study or clinical trial.

Exclusion Criteria

  • Patients 22 years and older at the time of treatment start.

 

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Nadia Laack, M.D.

Open for enrollment

Contact information:

Justine Buroker M.B.A.

(507) 293-0624

Buroker.Justine@mayo.edu

More information

Publications

Publications are currently not available

Additional contact information

Cancer-related trials contact form

Phone: 855-776-0015 (toll-free)

International patient clinical studies questions